These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10231461)

  • 1. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
    Tsukushi S; Katsuzaki T; Aoyama I; Takayama F; Miyazaki T; Shimokata K; Niwa T
    Kidney Int; 1999 May; 55(5):1970-6. PubMed ID: 10231461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
    Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
    Hamada Y; Nakamura J; Naruse K; Komori T; Kato K; Kasuya Y; Nagai R; Horiuchi S; Hotta N
    Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone.
    Niwa T; Tsukushi S
    Kidney Int Suppl; 2001 Feb; 78():S37-41. PubMed ID: 11168980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication.
    Niwa T
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):23-36. PubMed ID: 10491986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
    Niwa T; Katsuzaki T; Miyazaki S; Miyazaki T; Ishizaki Y; Hayase F; Tatemichi N; Takei Y
    J Clin Invest; 1997 Mar; 99(6):1272-80. PubMed ID: 9077536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
    Jono T; Nagai R; Lin X; Ahmed N; Thornalley PJ; Takeya M; Horiuchi S
    J Biochem; 2004 Sep; 136(3):351-8. PubMed ID: 15598892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
    Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
    Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes.
    Niwa T; Katsuzaki T; Ishizaki Y; Hayase F; Miyazaki T; Uematsu T; Tatemichi N; Takei Y
    FEBS Lett; 1997 May; 407(3):297-302. PubMed ID: 9175872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of polyol pathway in nonenzymatic glycation.
    Hamada Y; Araki N; Horiuchi S; Hotta N
    Nephrol Dial Transplant; 1996; 11 Suppl 5():95-8. PubMed ID: 9044317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
    Ando H; Takamura T; Nagai Y; Kaneko S;
    J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
    Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
    Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
    Wihler C; Schäfer S; Schmid K; Deemer EK; Münch G; Bleich M; Busch AE; Dingermann T; Somoza V; Baynes JW; Huber J
    Diabetologia; 2005 Aug; 48(8):1645-53. PubMed ID: 16010524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
    Li W; Hamada Y; Nakashima E; Naruse K; Kamiya H; Akiyama N; Hirooka H; Takahashi N; Horiuchi S; Hotta N; Oiso Y; Nakamura J
    Biochem Biophys Res Commun; 2004 Feb; 314(2):370-6. PubMed ID: 14733914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.